StockData
ResMed Inc logo

ResMed Inc (RMD) stock

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3014% below fair value
$237.85−0.34 (-0.14%)

Close on Nov 17, 2026Market cap $33.46BP/E 21.7Yield 1.01%

ResMed total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

ResMed's total debt was $159.98M at Sep 30, 2026. For fiscal 2026 it was $259.95M, up 2525.8% from the year before. Over ten years it grew -14.0% a year on average. The highest annual figure on record is $1.17B in fiscal 2016.

Annual total debt

PeriodPeriod endValueChange
FY2026Jun 30, 2026$259.95M+2525.8%
FY2025Jun 30, 2025$9.90M0.0%
FY2024Jun 30, 2024$9.90M-0.0%
FY2023Jun 30, 2023$9.90M-0.1%
FY2022Jun 30, 2022$9.92M-17.4%
FY2021Jun 30, 2021$12.00M+0.1%
FY2020Jun 30, 2020$11.99M-0.0%
FY2019Jun 30, 2019$11.99M+4.6%
FY2018Jun 30, 2018$11.47M-98.9%
FY2017Jun 30, 2017$1.08B-8.0%
FY2016Jun 30, 2016$1.17B+290.2%
FY2015Jun 30, 2015$300.59M-0.1%
FY2014Jun 30, 2014$300.79M+0.0%
FY2013Jun 30, 2013$300.79M+19.9%
FY2012Jun 30, 2012$250.84M+150.4%
FY2011Jun 30, 2011$100.16M-17.7%
FY2010Jun 30, 2010$121.69M–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$159.98M-38.4%
Q4 FY2026CQ2 2026Jun 30, 2026$259.95M+2525.8%
Q3 FY2026CQ1 2026Mar 31, 2026$259.93M+2523.9%
Q2 FY2026CQ4 2025Dec 31, 2025$259.91M+2523.7%
Q1 FY2026CQ3 2025Sep 30, 2025$259.90M+2526.3%
Q4 FY2025CQ2 2025Jun 30, 2025$9.90M0.0%
Q3 FY2025CQ1 2025Mar 31, 2025$9.91M+0.0%
Q2 FY2025CQ4 2024Dec 31, 2024$9.91M+0.1%
Q1 FY2025CQ3 2024Sep 30, 2024$9.90M-0.1%
Q4 FY2024CQ2 2024Jun 30, 2024$9.90M-0.0%
Q3 FY2024CQ1 2024Mar 31, 2024$9.90M+0.0%
Q2 FY2024CQ4 2023Dec 31, 2023$9.90M-0.0%
Q1 FY2024CQ3 2023Sep 30, 2023$9.91M-0.0%
Q4 FY2023CQ2 2023Jun 30, 2023$9.90M-0.1%
Q3 FY2023CQ1 2023Mar 31, 2023$9.90M-17.3%
Q2 FY2023CQ4 2022Dec 31, 2022$9.90M-17.5%
Q1 FY2023CQ3 2022Sep 30, 2022$9.91M-17.4%
Q4 FY2022CQ2 2022Jun 30, 2022$9.92M-17.4%
Q3 FY2022CQ1 2022Mar 31, 2022$11.97M-0.2%
Q2 FY2022CQ4 2021Dec 31, 2021$12.00M+0.1%
Q1 FY2022CQ3 2021Sep 30, 2021$12.00M+0.1%
Q4 FY2021CQ2 2021Jun 30, 2021$12.00M+0.1%
Q3 FY2021CQ1 2021Mar 31, 2021$11.99M+0.0%
Q2 FY2021CQ4 2020Dec 31, 2020$11.99M+0.0%
Q1 FY2021CQ3 2020Sep 30, 2020$11.99M-0.0%
Q4 FY2020CQ2 2020Jun 30, 2020$11.99M-0.0%
Q3 FY2020CQ1 2020Mar 31, 2020$11.99M-2.9%
Q2 FY2020CQ4 2019Dec 31, 2019$11.98M+0.1%
Q1 FY2020CQ3 2019Sep 30, 2019$11.99M+0.1%
Q4 FY2019CQ2 2019Jun 30, 2019$11.99M+4.6%
Q3 FY2019CQ1 2019Mar 31, 2019$12.35M-98.8%
Q2 FY2019CQ4 2018Dec 31, 2018$11.98M-98.8%
Q1 FY2019CQ3 2018Sep 30, 2018$11.98M-98.9%
Q4 FY2018CQ2 2018Jun 30, 2018$11.47M-99.0%
Q2 FY2018CQ4 2017Dec 31, 2017$1.02B-12.8%
Q1 FY2018CQ3 2017Sep 30, 2017$1.02B–
Q4 FY2017CQ2 2017Jun 30, 2017$1.08B–
Q3 FY2017CQ1 2017Mar 31, 2017$1.17B–
Q2 FY2017CQ4 2016Dec 31, 2016$1.17B–

More ResMed figures

See a number that looks wrong?